RCEL Positive Sentiment
Full-Thickness Skin Defects ("FTSD") Market Sizing - June 2023 Update Market Size Additional Market Opportunity (1) (1) Prior to FDA Approval with FDA Approved Expanded Indication of FTSD Traumatic Wounds Traumatic Wound
Monday, June 26, 2023 BiopharmaWatch Research 1 min read Key Takeaway: The June 2023 update on the full-thickness skin defects (FTSD) market reveals a substantial market opportunity, identifying approximately 391,000 eligible procedures across various types of wounds including traumatic, surgical, and chronic conditions. This update is particularly relevant as it coincides with the FDA's approval of expanded indications for FTSD treatments. The report highlights significant types of wounds such as degloving injuries, cancer excisions, and pressure ulcers, underscoring the diverse applications of FTSD therapies. Overall, the findings indicate a promising potential for market growth and increased therapeutic adoption.
Full Press Release Details
Sizing - June 2023 Update Market Size Additional Market Opportunity (1) (1) Prior to FDA Approval with FDA Approved Expanded Indication of FTSD Traumatic Wounds Traumatic Wounds Surgical Wounds Data Degloving (Open Wounds) 99,000
Gun Shot Wounds Muscle-only Flap pending Data Crush 2,000 Traumatic Hematoma Laparotomy pending Abrasion 5,000 Abdominoplasty Dehiscence Laceration 10,000 Hidradenitis
Suppurativa Puncture 2,000 Chronic Wounds Surgical Excision - Cancer Surgical Wounds DFU 21,000 Cancer Excision 136,000 Necrotizing Fasciitis 2,000 VLU 42,000 Amputation 6,000 Non -
Pressure Ulcers 51,000 Fasciotomy 1,000 Pressure Ulcers 14,000 ~127,000 Eligible Procedures > 264,000 Eligible Procedures Total Market Opportunity of Traumatic, Surgical, Cancer Excision & Chronic Wounds ~391,000 Annual